Zobair Younossi, MD, MPH
Aldafermin Shown to Reduce ELF Scores in Patients With MASH Cirrhosis
A trial evaluating aldafermin has found it effective and largely well tolerated in patients with compensated ...
FEBRUARY 20, 2024
Registry Finds NAFLD, NASH Not So Silent After All
Patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis can suffer a variety of related ...
MAY 13, 2021
Load more